Effects of single-dose infusion of pyridoxalated-hemoglobin-polyoxyethylene conjugate solution on canine renal function. 1991

T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
Department of Biomedical Engineering & Applied Therapeutics, Cleveland Clinic Foundation, OH 44195-5132.

Pyridoxalated-hemoglobin-polyoxyethylene conjugate (PHP) is an acellular oxygen-carrying red blood cell substitute made from outdated human red blood cells. This study assessed the effect of PHP on renal function when PHP was infused with a clinically relevant dosage. A single dose of PHP that contains 8% wt/vol each of hemoglobin and maltose or an 8% maltose control solution was infused into the intact circulation of eight dogs (five dogs for PHP and three for the control; 20 ml/kg each, at the rate of 2.5 ml/h/kg for 8 h) in the awake state. Serial measurements of glomerular filtration rate (GFR) and renal plasma flow (RPF) were carried out before and after infusion for up to 2 weeks, along with determinations of urine volume flow rate, fractional excretion of sodium (FES), and free water clearance (CH2O). The results showed an elevation of plasma colloid osmotic pressure by an average of 4.4 mm Hg immediately postinfusion with PHP solution. An average 23% decrease in GFR, without notable changes in RPF immediately postinfusion, was observed in the PHP group; the value returned to the preinfusion level by 1 week postinfusion. Increases in parameters such as urine output, FES, and CH2O, which were more pronounced in the PHP group, were observed for 24 h after the infusion in both groups. Light microscopic examination of kidney specimens taken at 2 weeks postinfusion revealed a slight degree of vacuole formation in approximately 80% of the proximal tubules in the PHP group. The tubules were devoid of typical pathologic features of acute renal failure, and the vacuoles did not cause any observable changes in the assessed tubular functions.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007687 Kidney Tubules, Proximal The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE. Proximal Kidney Tubule,Proximal Renal Tubule,Kidney Tubule, Proximal,Proximal Kidney Tubules,Proximal Renal Tubules,Renal Tubule, Proximal,Renal Tubules, Proximal,Tubule, Proximal Kidney,Tubule, Proximal Renal,Tubules, Proximal Kidney,Tubules, Proximal Renal
D008297 Male Males
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D001802 Blood Substitutes Substances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs. Artificial Blood,Artificial Erythrocytes,Artificial Hemoglobin,Blood, Artificial,Erythrocyte Substitutes,Hemoglobin Substitutes,Red Cell Substitutes,Artificial Bloods,Artificial Erythrocyte,Artificial Hemoglobins,Blood Substitute,Bloods, Artificial,Cell Substitute, Red,Cell Substitutes, Red,Erythrocyte Substitute,Erythrocyte, Artificial,Erythrocytes, Artificial,Hemoglobin Substitute,Hemoglobin, Artificial,Hemoglobins, Artificial,Red Cell Substitute,Substitute, Blood,Substitute, Erythrocyte,Substitute, Hemoglobin,Substitute, Red Cell,Substitutes, Blood,Substitutes, Erythrocyte,Substitutes, Hemoglobin,Substitutes, Red Cell
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006454 Hemoglobins The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements. Eryhem,Ferrous Hemoglobin,Hemoglobin,Hemoglobin, Ferrous
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
September 1998, Biochemical and biophysical research communications,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
July 1998, Shock (Augusta, Ga.),
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
January 1988, ASAIO transactions,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
January 2000, Biochimica et biophysica acta,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
January 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
June 1990, Artificial organs,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
January 1987, ASAIO transactions,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
January 1997, Artificial cells, blood substitutes, and immobilization biotechnology,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
June 1995, Artificial organs,
T Takahashi, and K Iwasaki, and P S Malchesky, and H Harasaki, and H Emoto, and J B Goldcamp, and M Matsushita, and Y Nosé, and H Rolin, and P Hall
October 1992, Artificial organs,
Copied contents to your clipboard!